Jakavi (ruxolitinib)

$2,250.99

Jakavi (ruxolitinib) is a prescription medicine used to treat adults with myelofibrosis (MF), Polycythaemia vera (PV), or adult and pediatric patients 12 years and older with steroid-refractory acute graft-versus-host disease (GVHD) or chronic GVHD.

In the United States, this medicine is approved under the brand name Jakafi (ruxolitinib). This is the same medicine.